Stem cell therapy that can provide “promising” stem cell therapy for hair loss within five years

Researchers at the San Carlos Clinical Hospital in Madrid may target potential hair loss solutions.

A recent study injected mouse skin from human fat (fat-derived stem cells (ASC)” into mice’s skin function is a means of treating androgenic hair loss (AGA), which is male or female hair loss.

The team found that male mice achieved optimal hair regeneration after three weeks of receiving low-dose ASC and combined with an energy-promoting molecule called adenosine triphosphate (ATP).

Hair stylists and medical experts confirm temporary hair loss that affects Ozempic users

Low and high doses of ASC treatment and ATP did not cause hair regeneration in women, but medium doses of ASC plus ATP resulted in greater regeneration.

The researchers concluded that in the “all experimental groups”, male mice received stem cell solutions supplemented with ATP, improved.

These findings are published in the journal Stem Cell Research and Therapy.

Lead study author Dr. Eduardo López Bran is a dermatologist and professor at the University of Contract in Madrid – sharing his expectations for the study in an interview with Fox News Digital.

Expert warning

“We expect good results, but not that high success,” he said. “We are talking about the very high hair regeneration in both male and female mice.”

The researchers obtained a “very high percentage” of hair regeneration at the appropriate dose, noting that 100% of male mice and up to 90% of female mice re-colored their hair.

The researchers obtained a “very high percentage” of hair regeneration at the appropriate dose, noting that 100% of male mice and up to 90% of female mice re-colored their hair. (Not shown from actual mice in the study.) (iStock)

“These results suggest that advanced therapies may represent new treatments for many diseases and are currently no effective treatment,” Bran continued.

“This promising outcome achieved in the preclinical stage through a completely novel approach to androgenic hair loss – a method to avoid chronic treatment and also safe – is an important scientific milestone.”

“We’re talking about the hair regeneration in both male and female mice is very high.”

Bran noted that the main limitation of the study was the thinness of the mouse skin, which “posed a challenge in terms of treatment and treatment.”

Click here to get the Fox News app

“This requires a protocol to minimize experimental variability and will be a key factor at the beginning of human research,” he said.

“Research advances point to possible solutions that may provide long-term results in the future without the need for ongoing treatment to sustain benefits.” (iStock)

Bran warned that the new findings should be interpreted “cautiously and scientifically rigorously.”

“Although the results in mice represent significant progress, it does have to wait for the clinical benefits of humans to be confirmed.”

Click here to sign up for our health newsletter

Researchers encourage people with androgenic hair loss to continue consulting with dermatologists and follow prescribed treatments as the research progresses.

“It is important to stay hopeful. Research progress points to possible solutions that may provide long-term results in the future without the need for ongoing treatment to sustain the benefits.”

“This study is small and requires more research on this approach as a potential treatment option.”

The researchers note that researchers are studying clinical trials in humans to confirm the safety of moderate androgenic hair loss for men and women aged 18 to 50.

“If everything goes as expected, the most optimistic schedule points to the treatment that will be available in about five years,” he said.

Looking at clinical trials in humans, researchers are “actively” confirming moderate androgenic hair loss for men and women aged 18 to 50. (iStock)

In another interview with Dr. Brendan Camp, a dermatologist in New York, who was not involved in the research and commented on the potential of this approach.

He reiterated: “While it is not commercially available, this study shows that injecting ATP-enriched stem cells into the scalp skin may encourage hair regeneration in individuals with androgenic alopecia.”

For more health articles, please visit www.foxnews.com/health.

“This study is small and requires this approach as a potential therapeutic option for androgen hair loss.”

Prior to this, CAMP encouraged people to focus on currently available and “deeply studied” treatments to address hair loss and visit board-certified dermatologists for evaluation.